638 related articles for article (PubMed ID: 22267158)
1. Generic immunosuppression in solid organ transplantation: a Canadian perspective.
Harrison JJ; Schiff JR; Coursol CJ; Daley CJ; Dipchand AI; Heywood NM; Keough-Ryan TM; Keown PA; Levy GA; Lien DC; Wichart JR; Cantarovich M
Transplantation; 2012 Apr; 93(7):657-65. PubMed ID: 22267158
[TBL] [Abstract][Full Text] [Related]
2. What Is the Future of Generics in Transplantation?
van Gelder T
Transplantation; 2015 Nov; 99(11):2269-73. PubMed ID: 26050017
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of clinical and safety outcomes associated with conversion from brand-name to generic tacrolimus in transplant recipients enrolled in an integrated health care system.
Spence MM; Nguyen LM; Hui RL; Chan J
Pharmacotherapy; 2012 Nov; 32(11):981-7. PubMed ID: 23074134
[TBL] [Abstract][Full Text] [Related]
4. Generic immunosuppressants.
Medeiros M; Lumini J; Stern N; Castañeda-Hernández G; Filler G
Pediatr Nephrol; 2018 Jul; 33(7):1123-1131. PubMed ID: 28733752
[TBL] [Abstract][Full Text] [Related]
5. [Special considerations in generic substitution of immunosuppressive drugs in transplantation].
Remport A; Dankó D; Gerlei Z; Czebe K; Kiss I
Orv Hetil; 2012 Aug; 153(34):1341-9. PubMed ID: 22913916
[TBL] [Abstract][Full Text] [Related]
6. Generic immunosuppression in transplantation: current evidence and controversial issues.
El Hajj S; Kim M; Phillips K; Gabardi S
Expert Rev Clin Immunol; 2015 May; 11(5):659-72. PubMed ID: 25817258
[TBL] [Abstract][Full Text] [Related]
7. Generic Drugs - Decreasing Costs and Room for Increased Number of Kidney Transplantations.
Spasovski G
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(2):133-8. PubMed ID: 27442379
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of generic cyclosporine arpimune in Filipino low-risk primary kidney transplant recipients.
Pamugas GE; Danguilan RA; Lamban AB; Mangati VB; Ona ET
Transplant Proc; 2012 Jan; 44(1):101-8. PubMed ID: 22310590
[TBL] [Abstract][Full Text] [Related]
9. Generic cyclosporine formulations: more open questions than answers.
Cattaneo D; Perico N; Remuzzi G
Transpl Int; 2005 Apr; 18(4):371-8. PubMed ID: 15773953
[TBL] [Abstract][Full Text] [Related]
10. [Consensus statement of the Croatian Society for Nephrology, Dialysis and Transplantation regarding the use of generic immunosuppressive drugs].
Bašić-Jukić N; Rački S; Knotek M; Bubić-Filipi L; Bubić I; Zibar L; Kes P;
Acta Med Croatica; 2014 Apr; 68(2):211-4. PubMed ID: 26012162
[TBL] [Abstract][Full Text] [Related]
11. Generic tacrolimus in solid organ transplantation.
Taube D; Jones G; O'Beirne J; Wennberg L; Connor A; Rasmussen A; Backman L
Clin Transplant; 2014 May; 28(5):623-32. PubMed ID: 24750309
[TBL] [Abstract][Full Text] [Related]
12. Generic maintenance immunosuppression in solid organ transplant recipients.
Ensor CR; Trofe-Clark J; Gabardi S; McDevitt-Potter LM; Shullo MA
Pharmacotherapy; 2011 Nov; 31(11):1111-29. PubMed ID: 22026398
[TBL] [Abstract][Full Text] [Related]
13. Generics: are all immunosuppression agents created equally?
Hauch A; John M; Smith A; Dortonne I; Patel U; Kandil E; Killackey M; Paramesh A; Lee B; Zhang R; Buell JF
Surgery; 2015 Oct; 158(4):1049-54; discussion 1054-5. PubMed ID: 26206317
[TBL] [Abstract][Full Text] [Related]
14. A multicenter experience with generic tacrolimus conversion.
McDevitt-Potter LM; Sadaka B; Tichy EM; Rogers CC; Gabardi S
Transplantation; 2011 Sep; 92(6):653-7. PubMed ID: 21788920
[TBL] [Abstract][Full Text] [Related]
15. Methods, strengths, weaknesses, and limitations of bioequivalence tests with special regard to immunosuppressive drugs.
van Gelder T; Gabardi S
Transpl Int; 2013 Aug; 26(8):771-7. PubMed ID: 23441971
[TBL] [Abstract][Full Text] [Related]
16. Generic immunosuppression in solid organ transplantation: systematic review and meta-analysis.
Molnar AO; Fergusson D; Tsampalieros AK; Bennett A; Fergusson N; Ramsay T; Knoll GA
BMJ; 2015 Jun; 350():h3163. PubMed ID: 26101226
[TBL] [Abstract][Full Text] [Related]
17. Generic cyclosporine: a word of caution.
Ponticelli C
J Nephrol; 2004; 17 Suppl 8():S20-4. PubMed ID: 15599881
[TBL] [Abstract][Full Text] [Related]
18. Rurality and other factors associated with adherence to immunosuppressant medications in community-dwelling solid-organ transplant recipients.
Sankaranarayanan J; Collier D; Furasek A; Reardon T; Smith LM; McCartan M; Langnas AN
Res Social Adm Pharm; 2012; 8(3):228-39. PubMed ID: 21856247
[TBL] [Abstract][Full Text] [Related]
19. The generics in transplantation and the rules on their use.
Masri M
Exp Clin Transplant; 2003 Jun; 1(1):65-8. PubMed ID: 15859910
[TBL] [Abstract][Full Text] [Related]
20. A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients.
Shenoy S; Hardinger KL; Crippin J; Korenblat K; Lisker-Melman M; Lowell JA; Chapman W
Liver Transpl; 2008 Feb; 14(2):173-80. PubMed ID: 18236391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
